Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Tumor Necrosis Factor α Transcriptional Activation by Regulating Nuclear Factor-kB and cAMP Response Element-binding Protein/c-Jun
Open Access
- 1 November 1998
- journal article
- Published by Elsevier BV
- Vol. 273 (47), 31427-31436
- https://doi.org/10.1074/jbc.273.47.31427
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophagesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1997
- The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptorsPeptides, 1996
- Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) induce phosphorylation of the transcription factor CREB in subpopulations of rat pinealocytes: immunocytochemical and immunochemical evidenceCell and tissue research, 1996
- TGFβ1 Inhibits NF-κB/Rel Activity Inducing Apoptosis of B Cells: Transcriptional Activation of IκBαImmunity, 1996
- Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complexJournal of Neuroimmunology, 1994
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- The Pathophysiology of Tumor Necrosis FactorsAnnual Review of Immunology, 1992
- Interleukin-6: An OverviewAnnual Review of Immunology, 1990
- The Biology of Cachectin/TNF -- A Primary Mediator of the Host ResponseAnnual Review of Immunology, 1989
- Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase CBiochemical and Biophysical Research Communications, 1989